Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1996
10/23/1996CN1133839A Aroyl-piperidine derivatives
10/22/1996US5567828 For treatment of post-menopausal diseases, i.e., osteoporosis, cardiovascular disorders, cancer
10/22/1996US5567824 Catalyzing the cyclization in presence of a solvent and a proton acceptor
10/22/1996US5567820 Therapy for bone diseases
10/22/1996US5567818 Reduction; separation; dehydration
10/22/1996US5567814 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE
10/22/1996US5567807 Using an anionic exchange resin
10/22/1996US5567804 Human leucocyte elastase inhibitor; antioxidant
10/22/1996US5567734 Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them
10/22/1996US5567728 Receptor ligands
10/22/1996US5567726 Selective agonists of 5-hydroxytryptamine-like receptors; useful in treatment of migraine and associated disorders
10/22/1996US5567724 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
10/22/1996US5567718 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors
10/22/1996US5567715 1-benzothiophene derivatives
10/22/1996US5567714 Methods of treating obesity by inhibiting physiological conditions associated with an excess of neuropeptide Y
10/22/1996US5567712 Naphthyl compounds, intermediates, compositions and methods
10/22/1996US5567702 Combination of pyrimidine derivatives and retinoids, as separate components, for inducing and stimulating hair growth and reducing its loss
10/22/1996US5567700 Useful for treating asthma
10/22/1996US5567689 Methods for increasing uridine levels with L-nucleosides
10/22/1996US5567686 Method for protection against genotoxic mutagenesis
10/22/1996US5567609 Antigrowth agents
10/22/1996US5567425 Plant extracts
10/22/1996US5567409 Administering a tetrapyrrole carboxylic acid in sufficient quantity to accumulate in arthritic lesion; applying light to cause it to produce fluorescence
10/22/1996CA2050822C Intermediate for making 3-oxo-4-aza-androst-1-ene 17-.beta.-ketones
10/22/1996CA2007655C Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
10/22/1996CA1338671C Light-induced killing of carcinoma cells
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/21/1996CA2174602A1 .alpha.-glucosidase inhibitor, composition principally comprising sugar and containing the same, sweetener, food and feed
10/20/1996CA2172884A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
10/17/1996WO1996032408A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
10/17/1996WO1996032386A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/17/1996WO1996032385A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
10/17/1996WO1996032382A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996WO1996032381A1 Carbazole derivative
10/17/1996WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
10/17/1996WO1996032379A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
10/17/1996WO1996032119A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996WO1996032115A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032105A1 Lactacystin analogs
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996016173A3 Modified proteinase inhibitors
10/17/1996WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996DE19512484A1 Kohlenhydratmodifizierte Cytostatika Carbohydrate-modified cytostatics
10/17/1996CA2220827A1 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors
10/17/1996CA2217951A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996CA2217817A1 Lactacystin analogs
10/17/1996CA2217707A1 Indole derivatives as cgmp-pde inhibitors
10/17/1996CA2215389A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996CA2212356A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
10/17/1996CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737685A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
10/16/1996EP0737680A1 (Phenylalkylaminoalkyloxyl)-hetero-aryl compounds, processes and intermediates for their preparation and medicaments containing these compounds
10/16/1996EP0737678A1 4-Indolylpiperazinyl derivatives
10/16/1996EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
10/16/1996EP0737199A1 Method for preparing concentrated biologically active silicon compounds
10/16/1996EP0737196A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
10/16/1996EP0737195A1 New ginkgolide derivatives and a process for preparing them
10/16/1996EP0737192A1 Substituted morpholine derivatives and their use as therapeutic agents
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0737070A1 Vitamin d 3? analogues and pathway to mediate disorders
10/16/1996EP0737067A1 Method of treatment of hormone-unresponsive metastatic prostate cancer
10/16/1996EP0589957B1 Use of atipamezole for the treatment of male sexual impotence
10/16/1996EP0571546B1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity
10/16/1996CN1133596A 'Delta' 16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors
10/16/1996CN1133593A Piperazine compounds used in therapy
10/16/1996CN1133289A Substituted 4-phenyl thiazole derivant, preparation and medicine compositions thereof
10/16/1996CN1133288A Compound with 1-(aryl Chain olefine)-4-(aryl methyl) piperazine structure, preparation process thereof and medicine thereof
10/16/1996CN1133173A Preparation of diuretic by using neuropsychic tension antagonist
10/16/1996CN1033034C Method for preparation of crystalline interleukin-4
10/16/1996CN1033032C Prepn. of 19-substituted progesterone derivatives
10/16/1996CN1033029C Prepn. of indenoindole compound
10/15/1996US5565589 17-formyl-5,6-trans-vitamin D compounds
10/15/1996US5565580 Treatment of central nervous system disorders
10/15/1996US5565562 Triaza macrocycles
10/15/1996US5565495 Periodically administering selegiline (or salt) to middle-aged dog
10/15/1996US5565488 Oxalylamino-benzofuran- and benzothienyl-derivatives
10/15/1996US5565486 Administering culture product of the fungus acremonium strictum as an anticonvulsant, anxiolytic agent, muscle relaxant, hypnotic or memory enhancer
10/15/1996US5565480 Substituted histidines
10/15/1996US5565476 Renin inhibitors for treatment of congestive heart failure and hypertension
10/15/1996US5565474 1-heteroarylazetidines and -pyrrolidines process for their preparation and pharmaceutical compositions containing them
10/15/1996US5565469 Benzimidazoles and pharmaceutical compositions containing them
10/15/1996US5565467 Androstenone derivative
10/15/1996US5565464 Compounds having angiotensine II antagonistic activity
10/15/1996US5565463 9-subtituted-8-unsubstituted-9-deazaguanines
10/15/1996US5565455 Method for treating substance abuse disorders
10/15/1996US5565448 Antiinflammatory agent, cardiovascular disorders, septic shock
10/15/1996US5565433 Administering in treatment and prevention of inflammatory diseases
10/15/1996US5565432 Smooth muscle cell proliferation inhibitors
10/15/1996US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
10/15/1996US5565424 Vasoactive intestinal peptide antagonists useful as antitumor and anticancer agents
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996CA2067498C Composition for inducing granulocyte production or b cell production in peripheral blood
10/15/1996CA1338647C Inhibitors of lysyl oxidase
10/15/1996CA1338646C (arylsulphonyl) nitromethanes, processes for their preparation and their use in pharmaceutical compositions
10/13/1996WO1996033727A1 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
10/13/1996CA2216854A1 A novel use of (s)-adenosyl-l-methionine (same)
10/11/1996CA2173690A1 4-indolylpiperazinyl derivatives
1 ... 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 ... 1564